Theranos Sticky Post-it Note Pad
3" x 3" / White
$10.99
Product Details & Size Guide
GhostCorp Apparel - resurrecting iconic corporate ghosts.
Keep everyday reminders close with a note pad inspired by Theranos, the Palo Alto health-technology company founded in 2003. Theranos became one of the most visible names in 2010s Silicon Valley, known for its ambitious blood-testing claims, partnerships with Safeway and Walgreens, and dramatic public history. This is a conversation-starting desk accessory for collectors drawn to discontinued brands, startup culture, and corporate-history ephemera.
Theranos Inc. was an American privately held health technology company founded in 2003 by Elizabeth Holmes after she left Stanford University. The business was originally called Real-Time Cures before Holmes renamed it Theranos, combining the words therapy and diagnosis. Based in California, it promoted blood testing using small samples collected by finger prick, a vessel called the nanotainer, and an analysis device called the Edison. Theranos moved to 1601 S. California Ave. in Palo Alto in June 2012 and later operated from Page Mill Road, with laboratories in Newark, California, and Scottsdale, Arizona. Partnerships included Safeway in 2012 and Walgreens in 2013, but both relationships ended after questions about the technology and testing practices. Regulatory actions, lawsuits, and investigations followed. Theranos ceased operations in September 2018 after failing to find a buyer. Its patents were transferred to Fortress Investment Group in exchange for cash assets to be distributed to creditors.
Keep everyday reminders close with a note pad inspired by Theranos, the Palo Alto health-technology company founded in 2003. Theranos became one of the most visible names in 2010s Silicon Valley, known for its ambitious blood-testing claims, partnerships with Safeway and Walgreens, and dramatic public history. This is a conversation-starting desk accessory for collectors drawn to discontinued brands, startup culture, and corporate-history ephemera.
Theranos Inc. was an American privately held health technology company founded in 2003 by Elizabeth Holmes after she left Stanford University. The business was originally called Real-Time Cures before Holmes renamed it Theranos, combining the words therapy and diagnosis. Based in California, it promoted blood testing using small samples collected by finger prick, a vessel called the nanotainer, and an analysis device called the Edison. Theranos moved to 1601 S. California Ave. in Palo Alto in June 2012 and later operated from Page Mill Road, with laboratories in Newark, California, and Scottsdale, Arizona. Partnerships included Safeway in 2012 and Walgreens in 2013, but both relationships ended after questions about the technology and testing practices. Regulatory actions, lawsuits, and investigations followed. Theranos ceased operations in September 2018 after failing to find a buyer. Its patents were transferred to Fortress Investment Group in exchange for cash assets to be distributed to creditors.
Keep a stack by the phone for action items, stash a pad in your planner for weekly priorities, or place one on a conference table where everyone can jot a quick note. The adhesive holds through handling but releases cleanly when you move items around. For people who prefer minimal branding and maximum writing space, these pads help keep thoughts visible and tasks moving forward without shouting for attention.
Product features
- 50 sheets per pad with one printed side
- 75.2 gsm white uncoated paper for smooth writing
- 3M Post-it® adhesive with branded backing sheet
- Available in seven sizes; assembled in the USA
- Vibrant, crisp corner print using modern printing techniques
| 3" x 3" | 4" x 3" | 4" x 4" | |
| Width, in | 2.99 | 4.02 | 4.02 |
| Height, in | 2.87 | 2.87 | 3.86 |
EU representative: HONSON VENTURES LIMITED, gpsr@honsonventures.com, 3, Gnaftis House flat 102, Limassol, Mesa Geitonia, 4003, CY
Product information: Post-it®, 2 year warranty in EU and Northern Ireland as per Directive 1999/44/EC